Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Elevation Oncology Inc
ELEVCurrent price
0.67 USD
+0.02 USD (+3.09%)
Last closed
0.65 USD
Company
elevationoncology.com
ISIN
US28623U1016
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
38 421 504 USD
Yield for 12 month
+75.12 %
1Y
3Y
5Y
10Y
15Y
ELEV
Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a clinically validated molecular target. Its EO-3021 selectively delivers a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Elevation Oncology, Inc. has a license agreement with CSPC Megalith Biopharmaceutical Co., Ltd. to develop and commercialize EO-3021. The company was formerly known as 14ner Oncology, Inc. and changed its name to Elevation Oncology, Inc. in February 2020. The company was incorporated in 2019 and is based in Boston, Massachusetts. Address: 101 Federal Street, Boston, MA, United States, 02110
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-39 000 USD
Last Year
-27 000 USD
Current Quarter
-5 000 USD
Last Quarter
-4 000 USD
Key Figures ELEV
1 year
3 years
5 years
10 years
EBITDA
-41 978 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.46 %
PEG Ratio
–
Return On Equity TTM
-63.67 %
Wall Street Target Price
7 USD
Revenue TTM
–
Book Value
1.17 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.8 USD
Diluted Eps TTM
-0.8 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ELEV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ELEV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ELEV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.0848
Price Book MRQ
0.5539
Financials ELEV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ELEV
For 52 weeks
0.37 USD
5.83 USD
50 Day MA
0.59 USD
Shares Short Prior Month
6 148 989
200 Day MA
2.56 USD
Short Ratio
8.34
Shares Short
5 948 373
Short Percent
10.63 %
BeatStart